CORRADINI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 13.336
EU - Europa 7.752
AS - Asia 5.619
SA - Sud America 828
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 135
OC - Oceania 38
Totale 27.889
Nazione #
US - Stati Uniti d'America 12.949
SE - Svezia 2.246
IT - Italia 1.935
SG - Singapore 1.600
CN - Cina 1.549
GB - Regno Unito 1.357
BR - Brasile 628
DE - Germania 610
VN - Vietnam 597
HK - Hong Kong 547
FI - Finlandia 437
BD - Bangladesh 359
KR - Corea 261
FR - Francia 227
CA - Canada 205
RU - Federazione Russa 200
UA - Ucraina 185
NL - Olanda 141
TR - Turchia 134
IN - India 124
ID - Indonesia 95
AR - Argentina 77
BG - Bulgaria 63
MX - Messico 62
JP - Giappone 59
PL - Polonia 48
LT - Lituania 43
IQ - Iraq 40
IE - Irlanda 38
AU - Australia 34
BE - Belgio 34
PK - Pakistan 33
ES - Italia 32
ZA - Sudafrica 32
AT - Austria 30
AE - Emirati Arabi Uniti 28
CR - Costa Rica 28
RO - Romania 27
IL - Israele 26
EC - Ecuador 24
CL - Cile 23
CO - Colombia 23
MA - Marocco 23
MY - Malesia 22
CH - Svizzera 21
UZ - Uzbekistan 19
VE - Venezuela 19
SA - Arabia Saudita 17
DZ - Algeria 14
JM - Giamaica 14
PR - Porto Rico 13
EG - Egitto 12
HN - Honduras 12
NI - Nicaragua 12
AZ - Azerbaigian 11
PY - Paraguay 11
TN - Tunisia 11
JO - Giordania 10
TW - Taiwan 10
KE - Kenya 9
KZ - Kazakistan 9
PT - Portogallo 9
BO - Bolivia 8
IR - Iran 8
NP - Nepal 8
PH - Filippine 8
GT - Guatemala 7
OM - Oman 7
SC - Seychelles 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AL - Albania 6
CW - ???statistics.table.value.countryCode.CW??? 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
PE - Perù 6
RS - Serbia 6
BY - Bielorussia 5
DK - Danimarca 5
GP - Guadalupe 5
LB - Libano 5
LU - Lussemburgo 5
SI - Slovenia 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KH - Cambogia 4
KW - Kuwait 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
AO - Angola 3
EE - Estonia 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 27.666
Città #
Stockholm 1.799
Ashburn 1.482
Santa Clara 1.080
Singapore 1.012
Fairfield 869
Southend 821
San Jose 792
Hefei 543
Hong Kong 538
Council Bluffs 514
Woodbridge 490
Chandler 485
Houston 424
Helsinki 368
Dallas 329
London 323
Seattle 308
Los Angeles 293
Cambridge 278
Jacksonville 263
Wilmington 260
Nyköping 255
Beijing 254
Chicago 254
Seoul 231
Modena 224
Ann Arbor 209
Berlin 208
Dearborn 208
Ho Chi Minh City 200
New York 184
Milan 169
Hanoi 148
The Dalles 133
San Diego 103
Bologna 98
Sunnyvale 91
Rome 86
Boardman 79
Princeton 73
São Paulo 70
Phoenix 69
Lauterbourg 65
Buffalo 64
Orem 62
Munich 61
Shanghai 61
Sofia 61
Moscow 60
Frankfurt am Main 58
Jakarta 56
Izmir 54
Toronto 54
Atlanta 53
Eugene 50
San Francisco 49
Parma 48
Salt Lake City 46
Redwood City 45
Denver 41
Montreal 40
Amsterdam 39
Warsaw 38
Tokyo 37
Bremen 36
Columbus 36
North Bergen 36
Yalova 33
Maidenhead 32
Brooklyn 30
Reggio Emilia 30
Naples 29
Dublin 28
Brussels 27
Elk Grove Village 27
Des Moines 26
Florence 26
Nuremberg 26
Da Nang 24
Kent 24
Redondo Beach 24
San José 24
Haiphong 23
Tampa 23
Bari 22
Chennai 22
Mexico City 22
Turin 21
Paris 20
Rio de Janeiro 20
Philadelphia 19
Borzano 18
Rimini 18
Hải Dương 17
Turku 17
Washington 17
Baghdad 16
Formigine 16
Hemrik 16
Memphis 16
Totale 18.620
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.860
EASL Clinical Practice Guidelines on haemochromatosis 941
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 614
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 556
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 530
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 521
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 475
Non-HFE Hepatic Iron Overload. 455
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 449
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 431
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 431
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 426
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 422
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 389
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 387
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 382
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 376
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 373
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 365
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 363
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 360
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 359
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 357
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 354
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 352
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 350
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 343
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 342
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 342
Iron and steatohepatitis. 329
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 327
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 321
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 311
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 304
Disease progression and liver cancer in the ferroportin disease 300
Lack of enterocyte iron accumulation in the ferroportin disease 297
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 294
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 293
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 283
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 281
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 279
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 278
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 278
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 277
Iron Metabolism in the Disorders of Heme Biosynthesis 272
Fifty meanings of grey 269
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 265
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 264
The RGM/DRAGON family of BMP co-receptors. 263
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 261
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 257
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 253
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 245
Hereditary hemochromatosis. 244
Genetic iron overload disorders 240
Hereditary Hemochromatosis 237
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 229
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 228
Post COVID-19 irritable bowel syndrome 218
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 218
Impact of natural neuromedin-B receptor variants on iron metabolism 217
Idiopathic brain calcification in a patient with hereditary hemochromatosis 216
Hyperferritinemia and diagnosis of type 1 Gaucher disease 215
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 213
Fortune favours the bold: finding the right route in the anemia's sea 211
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 204
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 197
Hereditary Haemochromatosis: the genes and the disease. 194
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 192
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 191
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 189
Iron and the liver 187
null 186
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 177
Iron in Porphyrias: Friend or Foe? 176
Fegato, pancreas e vie biliari. 172
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 165
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 161
Haematological parameters in erythropoietic protoporphyria: A multi-national study 158
Haemochromatosis 158
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 157
Iron overload disorders 155
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 149
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 147
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 144
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 141
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 141
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 130
Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets. 124
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 122
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 115
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 113
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 79
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients 73
Totale 27.889
Categoria #
all - tutte 97.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.049 0 0 0 0 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/202610.805 560 426 816 817 883 677 1.051 485 2.833 995 594 668
2026/20273.717 479 1.081 1.025 1.045 87 0 0 0 0 0 0 0
Totale 27.889